BIOMAT Database Logo BIOMAT Database Logo

Impact of thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors. 1981

H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011828 Radiation Chimera An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells. Chimera, Radiation,Chimeras, Radiation,Radiation Chimeras
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II

Related Publications

H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
On the role of the thymus during the generation of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors.
June 1983, Transplantation proceedings,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Thymic influence on the T-lymphocyte self MHC repertoire. II. Cytotoxic T-lymphocyte precursors.
January 1988, Thymus,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Antigen-specific and MHC-restricted Plasmodium falciparum-induced human T lymphocyte clones.
August 1986, Journal of immunology (Baltimore, Md. : 1950),
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Differences in the MHC-restricted self-recognition repertoire of intra-thymic and extra-thymic cytotoxic T lymphocyte precursors.
March 1983, Journal of immunology (Baltimore, Md. : 1950),
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.
February 2006, Oncology reports,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Generation and characterization of peptide-specific, MHC-restricted cytotoxic T lymphocyte (CTL) and helper T cell lines from unprimed T cells under microculture conditions.
June 1990, Journal of immunological methods,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Genetic and stimulator cell requirements for generation and activation of minor histocompatibility antigen-specific memory cytotoxic T-lymphocyte precursors.
August 1988, Immunology,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
The role of CD8-mediated signals in the generation of MHC-restricted cytotoxic T lymphocyte effector cells.
February 1991, Transplantation proceedings,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Development of cytotoxic T lymphocyte precursors in the absence of the thymus.
February 1980, European journal of immunology,
H Wagner, and C Hardt, and H Stockinger, and K Pfizenmaier, and R Bartlett, and M Röllinghoff
Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo.
February 1998, The Journal of experimental medicine,
Copied contents to your clipboard!